鍏充簬<\/b> Novavax
<\/b>Novavax, Inc.锛堢撼鏂揪鍏嬭偂绁ㄤ唬鐮侊細NVAX) 閫氳繃鍙戠幇銆佺爺鍙戝拰鍟嗗敭鍒涙柊鎶€鏈柅鑻楋紝浠庤€岄槻姝㈡劅鏌撲弗閲嶄紶鏌撶梾锛屼績杩涘拰鏀瑰杽鍋ュ悍銆侼ovavax 鏄竴瀹舵€婚儴浣嶄簬缇庡浗椹噷鍏板窞鐩栫憻鏂牎鐨勫叏鐞冩€у叕鍙革紝鎻愪緵宸紓鍖栫殑鐤嫍骞冲彴锛岃骞冲彴缁撳悎浜嗛噸缁勮泲鐧芥柟娉曘€佸垱鏂扮殑绾崇背棰楃矑鎶€鏈拰 Novavax 鑾峰緱涓撳埄鐨� Matrix-M 浣愬墏锛屼互澧炲己鍏嶇柅鍙嶅簲銆侼ovavax 涓撴敞浜庡叏鐞冩渶绱ц揩鐨勫仴搴锋寫鎴橈紝鐩墠姝ｅ湪璇勪及鏂板啝鑲虹値銆佹祦鎰熷拰鏂板啝鑲虹値涓庢祦鎰熻仈鍚堢柅鑻椼€傛浜嗚В鏇村淇℃伅锛岃璁块棶 novavax.com<\/a> 鎴栭€氳繃 LinkedIn<\/a> 涓庢垜浠仈绯汇€�<\/p> \n
鍓嶇灮鎬у０鏄�<\/b> 鏈枃涓嚒娑夊強 Novavax 鐨勬湭鏉ャ€佽繍钀ヨ鍒掑拰鍓嶆櫙銆佹湭鏉ョ洃绠＄敵鎶ュ拰琛屽姩鐨勮寖鍥淬€佹椂闂村畨鎺掑強鍏跺奖鍝嶇瓑锛屽潎灞炰簬鍓嶇灮鎬ч檲杩帮紝鍖呮嫭 Novavax 鏂板啝鐤嫍銆佷綈鍓傦紙2023-2024 骞撮厤鏂癸級 (NVX-CoV2601) 鐨勬渶鏂� XBB 鐗堟湰鐨勪緵搴斿強鍏剁柅鑻楃殑浜や粯鍜屽垎閿€鏃堕棿鐨勮〃杩般€� Novavax 鐗规鎻愰啋锛屼笂杩板墠鐬绘€у０鏄庡彈鍒颁紬澶氶闄╁拰涓嶇‘瀹氬洜绱犲奖鍝嶏紝鍙兘瀵艰嚧瀹為檯缁撴灉涓庢绫婚檲杩版槑绀烘垨鏆楃ず鐨勭粨鏋滄湁閲嶅ぇ宸紓銆傝繖浜涢闄╁拰涓嶇‘瀹氬洜绱犲寘鎷絾涓嶉檺浜庯細鍗曠嫭鎴栦笌鍚堜綔浼欎即涓€璧锋弧瓒冲悇绉嶅畨鍏ㄣ€佹晥鍔涘拰浜у搧鐗规€ц姹傜殑鎸戞垬锛屽寘鎷弧瓒抽€傜敤鐨勭洃绠￠儴闂ㄨ姹傛墍闇€鐨勪笌宸ヨ壓璧勬牸鍜屽垎鏋愰獙璇佹湁鍏崇殑鎸戞垬锛涜幏寰楃█缂哄師鏉愭枡鍜屾秷鑰楀搧鏂归潰鐨勫洶闅撅紱Novavax 鍦ㄥ姹傛棦瀹氱洃绠¤矾寰勮兘鍔涙柟闈㈢殑璧勬簮闄愬埗锛堝寘鎷汉鍔涜祫鏈拰鍒堕€犺兘鍔涚瓑鏂归潰锛夛紱鍊欓€変骇鍝侊紙鍖呮嫭鏂板啝鐤嫍閽堝 XBB 鍙樼鐨勬洿鏂扮増鏈級鍦� 2023 骞寸瀛ｇ柅鑻楁帴绉嶅鎴栧湪鏈潵鏂板啝鐥呮瘨鍙樼鏍彂鐢熷彉鍖栨椂鍙婃椂鑾峰緱鐩戠鎺堟潈鏂归潰闈复鐨勬寫鎴樻垨寤惰锛涘湪杩涜涓村簥璇曢獙鏃跺嚭鐜版剰澶栨寫鎴樻垨寤惰锛涘埗閫犮€佸垎閿€鎴栧嚭鍙ｆ柟闈㈢殑寤惰鎴栨寫鎴橈紱Novavax 瀵� Serum Institute of India Pvt. Ltd. 琛€娓呯爺绌舵墍杩涜鍏卞悓閰嶅埗鍜岀亴瑁呯殑鍞竴渚濊禆锛屼互鍙婂叾杩愯惀鐨勪换浣曞欢璇垨涓柇瀵瑰鎴疯鍗曚氦浠樼殑褰卞搷锛涙垜浠殑鍩轰簬铔嬬櫧鐨勬洿鏂伴潪 mRNA XBB 鏂板啝鐤嫍銆丯VX-CoV2373 鎴栦换浣曞惈鏈夋柊鍐犲彉寮傛牚鐨勫埗鍓傚湪鑾峰緱鍟嗕笟搴旂敤鏂归潰鐨勬寫鎴橈紱婊¤冻涓庡涓晢涓氥€佹斂搴滃拰鍏朵粬瀹炰綋杈炬垚鐨勫崗璁腑鐨勫悎鍚岃姹傜殑鎸戞垬锛涗互鍙� Novavax 鎴嚦 2022 骞� 12 鏈� 31 鏃ョ殑 10-K 琛ㄦ牸骞村害鎶ュ憡鍜岄殢鍚庢彁浜ょ粰璇佸埜浜ゆ槗濮斿憳浼� (SEC) 鐨�10-Q 琛ㄦ牸瀛ｅ害鎶ュ憡涓殑"椋庨櫓鍥犵礌"鍜�"绠＄悊灞傚璐㈠姟鐘跺喌鍜岀粡钀ユ垚鏋滅殑璁ㄨ鍜屽垎鏋�"閮ㄥ垎纭畾鐨勫叾浠栭闄╁洜绱犮€� 鎴戜滑鎻愰啋鎶曡祫鑰呬笉瑕佽繃鍒嗕緷璧栨湰鏂伴椈绋夸腑鍖呭惈鐨勫墠鐬绘€ч檲杩般€傛湁鍏充笂杩板強鍏朵粬椋庨櫓鍜屼笉纭畾鎬х殑璁ㄨ锛屾垜浠紦鍔辨偍闃呰鎴戜滑鍚� SEC 鎻愪氦鐨勬枃浠讹紝璇疯闂� www.sec.gov<\/a> 鍜� www.novavax.com<\/a>锛屼互璁ㄨ杩欎簺浠ュ強鍏朵粬椋庨櫓鍜屼笉纭畾鎬с€傛湰鏂伴椈绋夸腑鐨勫墠鐬绘€у０鏄庝粎閫傜敤浜庢湰鏂囧彂甯冧箣鏃ョ殑鎯呭舰锛屾垜浠病鏈変箟鍔″鍏朵腑浠讳綍闄堣堪杩涜鏇存柊鎴栦慨璁€€傛垜浠殑涓氬姟鍙楀埌閲嶅ぇ椋庨櫓鍜屼笉纭畾鎬х殑褰卞搷锛屽寘鎷笂杩伴闄╁拰涓嶇‘瀹氭€с€傛姇璧勮€呫€佹綔鍦ㄦ姇璧勮€呭拰浠讳綍鍏朵粬浜哄＋搴斾粩缁嗚€冭檻杩欎簺鐩稿叧椋庨櫓鍜屼笉纭畾鍥犵礌銆�<\/p> \n
鑱旂郴鏂瑰紡锛�<\/b> 鎶曡祫鑰呭叧绯婚儴<\/u> Erika Schultz
240-268-2022
ir@novavax.com<\/a><\/p> \n
濯掍綋鍏崇郴閮�<\/u> Ali Chartan
240-720-7804
media@novavax.com<\/a><\/p> \n
1.Wherry EJ, Barouch DH. T cell immunity to COVID-19 vaccines. Science<\/i>. 2022;377(6608):821-822. doi:10.1126\/science.add2897.
2.Markov PV, Ghafari M, Beer M, et al. The evolution of SARS-CoV-2. Nat Rev Microbiol<\/i>. 2023;21(6):361-379. doi:10.1038\/s41579-023-00878-2.
3.缇庡浗椋熷搧鑽搧鐩戠潱绠＄悊灞€ (FDA)銆傛渶鏂扮増鏂板啝鐤嫍灏嗕簬 2023 骞寸瀛ｅ紑濮嬭幏鍑嗗湪缇庡浗浣跨敤銆�2023 骞� 6 鏈� 16 鏃ャ€� https:\/\/www.fda.gov\/vaccines-blood-biologics\/updated-covid-19-vaccines-use-united-states-beginning-fall-2023<\/a>銆�
4.娆ф床鑽搧绠＄悊灞€ (EMA)銆侲MA 鍜� ECDC 鍏充簬鏇存柊鏂板啝鐤嫍浠ラ拡瀵规柊鐨� SARS-CoV-2 鐥呮瘨鍙樼鐨勫０鏄庛€�2023 骞� 6 鏈� 6 鏃ャ€� https:\/\/www.ema.europa.eu\/en\/news\/ema-ecdc-statement-updating-covid-19-vaccines-target-new-sars-cov-2-virus-variants<\/a>.
5.涓栫晫鍗敓缁勭粐锛圵HO锛夈€俋BB.1.5 鏇存柊椋庨櫓璇勪及銆�2023 骞� 6 鏈� 20 鏃� https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/20230620xbb.1.5.pdf?sfvrsn=fff6f686_3<\/a>銆�<\/p> \n